Anti-SARS-CoV-2 Inactivated Vaccine in Patients With ANCA-Associated Vasculitis: Immunogenicity, Safety, Antibody Decay and the Booster Dose. Clinics 2022, 78, 100150. https://doi.org/10.1016/j.clinsp.2022.100150.